Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to prevent or treat hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium replacement in conditions causing potassium loss (e.g., diuretic use, vomiting, diarrhea). ## Adult Dosing * **Oral:** * Prevention: 20 mEq (1000 mg) once or twice daily. * Treatment: 40-100 mEq (2000-5000 mg) daily, divided into 2-5 doses. Maximum of 20 mEq per dose is often recommended to minimize GI upset. * **Intravenous:** * Treatment of hypokalemia: Typically administered at a rate not to exceed 10-20 mEq/hour. Higher rates (up to 40 mEq/hour) may be used in severe, life-threatening hypokalemia or cardiac arrest, but require continuous ECG monitoring and central venous access. * Concentration: Generally, no more than 40 mEq/L should be administered peripherally to avoid vein irritation. Higher concentrations (up to 80 mEq/L or more) can be given centrally. * Total daily dose: Usually 100-200 mEq (5000-10000 mg), but may vary based on severity and individual needs. Maximum recommended daily dose is often 200 mEq, but can be higher under close medical supervision. ## Pediatric Dosing * **Oral:** * Prevention: 1-2 mEq/kg/day, divided into 1-2 doses, not to exceed 100 mEq/day. * Treatment: 2-5 mEq/kg/day, divided into 2-4 doses, not to exceed 100 mEq/day. * **Intravenous:** * Dosing varies significantly by age, weight, and serum potassium level. Typical maintenance doses are 1-2 mEq/kg/day. * Corrective doses for hypokalemia depend on the severity. A common starting point for moderate hypokalemia might be 0.5-1 mEq/kg infused over 1-3 hours. * Maximum infusion rate: Generally 0.5-1 mEq/kg/hour (20 mEq/hour maximum). Higher rates require intensive monitoring. * Maximum concentration: Peripheral administration typically limited to 40 mEq/L. Central administration can be higher. * *Specific pediatric IV dosing requires careful calculation based on serum potassium levels and patient condition, often guided by institutional protocols.* ## Dose Adjustments * Renal impairment: Potassium is primarily excreted by the kidneys. Dose reduction is necessary in patients with impaired renal function. Monitor potassium levels closely. * Aldosteronism and certain diuretic use: May require higher doses. ## Contraindications * Hyperkalemia. * Conditions causing temporary potassium block at the cellular level (e.g., severe tissue trauma, extensive burns). * Anuria, oliguria, or progressing azotemia from renal disease. * Uncorrected adrenal insufficiency. * Certain cardiac conditions (e.g., undiagnosed EKG abnormalities). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain (especially with oral formulations). * **Serious:** Hyperkalemia (manifested by cardiac arrhythmias, muscle weakness, paresthesias, cardiac arrest), esophageal or gastric irritation/perforation (oral), vein irritation/phlebitis (IV), paradoxical worsening of myasthenia gravis. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and ARBs (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs:** May reduce potassium excretion, increasing risk of hyperkalemia. * **Heparin:** May inhibit aldosterone production, increasing risk of hyperkalemia. * **Digoxin:** Hypokalemia enhances digoxin toxicity. Hyperkalemia reduces digoxin's effect. * **Succinylcholine:** May cause transient hyperkalemia. ## Monitoring * Serum potassium levels (frequently, especially during IV therapy or dose changes). * Renal function (BUN, creatinine). * ECG (especially with rapid IV infusion or in patients with cardiac risk factors). * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with meals or a large glass of fluid to minimize gastrointestinal upset. * Swallow extended-release formulations whole; do not crush, chew, or suck on them. * Intravenous potassium chloride is a high-alert medication and must be administered with extreme caution, with careful attention to infusion rate and concentration. * In patients with vomiting or diarrhea, electrolyte losses should be assessed, and potassium replacement guided by serum levels. * Always ensure adequate renal function before administering potassium supplements. *** *Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your institution's guidelines before making any treatment decisions.*